By Siddhi Mahatole April 20 (Reuters) - U.S. drugmaker Eli Lilly will buy privately held biotech firm Kelonia Therapeutics ...

By Sriparna Roy April 17 (Reuters) - Eli Lilly's newly launched weight-loss pill was prescribed 1,390 times in the U.S. in ...

A deal could be reached as soon as Monday and could include additional payments tied to Kelonia meeting certain milestones, ...

Eli Lilly is in advanced talks to acquire biotech firm Kelonia ‌Therapeutics for more than $2 billion, the Wall ‌Street ...

Why Wall Street loves Lilly. So what does this Wall Street analyst like about Lilly? Yesterday, Eli Lilly announced it will ...

April 16 () - Eli Lilly said on Thursday its newly approved obesity ‌pill helped reduce the risk ‌of major cardiovascular ...

Eli Lilly's newly launched obesity pill was prescribed 1,390 times in the U.S. as of the week ended April 10, according to an ...

Early prescription volume signals uptake for an oral anti-obesity entrant, but competitive positioning versus oral ...

By Mariam Sunny April 22 (Reuters) - A delay in a Medicare pilot to cover obesity drugs due to health insurers' hesitation to participate in the program is unlikely to dent near-term demand for weight ...

April 20 (Reuters) - U.S. drugmaker Eli Lilly has agreed to buy privately held biotech firm Kelonia Therapeutics for up to $7 ...

April 20 (Reuters) - U.S. drugmaker Eli Lilly has agreed to buy privately held biotech firm Kelonia Therapeutics for up to $7 ...

The U.S. Food and Drug Administration is asking Eli Lilly and Company, the leading manufacturer of GLP-1s, for additional ...